News
ChatGPT Health regularly fails to identify when users need urgent medical attention and frequently misses signs of suicidal ideation, according to a study that experts warn could "feasibly lead to unnecessary harm and death." As reported by The Guardian, OpenAI launched the Health feature of ChatGPT to limited audiences in January, marketing it as a [...]
A new daily pill could offer a more effective oral GLP-1 option for weight loss, according to a clinical trial that may open the door to an improved non-injection alternative to Wegovy and Mounjaro. The drug, orforglipron, manufactured by Eli Lilly and prescribed for type 2 diabetes, targets the same GLP-1 receptors as oral semaglutide. [...]
German digital health startup Oska Health has raised €11 million in seed funding to expand its hybrid care model for patients living with chronic conditions. The round was led by Capricorn Partners and SwissHealth Ventures, with contributions from Revent, Calm Storm, LBBW Venture Capital, BMH, GoHub Ventures and Aurum Impact. The company combines trained health [...]
People living with dementia will help close a long-standing weakness in research - the clinical trial evidence gap - in a new home-based study. While those over 65 account for two-thirds of illness in the UK, they make up just one-third of trial participants. This "participation gap" means many life-saving drugs are tested on populations [...]
Novo Nordisk has struck a US$2.1bn deal with Vivtex to develop next-generation oral obesity and diabetes drugs, the companies said. Under the partnership, privately held Vivtex will license some of its oral drug-delivery technology, while Novo Nordisk will lead global development and commercialisation. Novo Nordisk will make an undisclosed upfront payment, alongside milestone payments and [...]
McDermott Will & Schulte advised Fidia Farmaceutici S.p.A. on its acquisition of Altacor Ltd, a UK‑based ophthalmic products company. The transaction marks a significant strategic step for Fidia as it enters the UK ophthalmology market directly, enhancing its presence in one of the group’s core therapeutic areas. Through the acquisition, Fidia expands its portfolio with [...]
YOU(th) has closed a US$4.5m funding round to expand its smartphone health screening platform, which uses AI and machine learning to assess health risks in under two minutes. The digital health company, which aims to expand preventive care globally, said rising interest in longevity among younger people alongside an ageing population is increasing demand for [...]
By Dr Tim Jobson, medical director, Predictive Health Intelligence “Intervention timing is everything. Case-finding enables this” Chronic liver disease is often diagnosed only after emergency presentation, when treatment options are limited and damage is irreversible. Because the disease is silent and carries stigma, patients are less likely to seek medical advice. At the same time, [...]
Brainomix has expanded its Series C round to £18.8m to scale its AI stroke and lung imaging platforms, with a focus on accelerating deployment in the US. The company added £4.8m to fund growth of its two core products. Brainomix 360 Stroke automates imaging assessment across the acute stroke pathway to support treatment and patient [...]
Kyndryl and the University of Liverpool have partnered on AI healthcare to explore how emerging technologies could be used to strengthen future health services. The collaboration brings together Kyndryl’s AI Innovation Lab, Kyndryl Consult AI expertise and Agentic AI Framework with the university’s Civic Health Innovation Labs and AI for Life Frontier research capability. Agentic [...]
